|
TXNRD3IT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71950009786315E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.69769984129198E-10 |
| Normal-vs-Stage2 |
3.31970000000403E-06 |
| Normal-vs-Stage3 |
6.10750006124761E-10 |
| Normal-vs-Stage4 |
5.94835292133666E-12 |
| Stage1-vs-Stage2 |
2.688400E-01 |
| Stage1-vs-Stage3 |
9.254800E-01 |
| Stage1-vs-Stage4 |
4.972300E-02 |
| Stage2-vs-Stage3 |
2.792000E-01 |
| Stage2-vs-Stage4 |
3.359600E-02 |
| Stage3-vs-Stage4 |
1.010180E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19450013716482E-10 |
| Normal-vs-AfricanAmerican |
2.620100E-04 |
| Normal-vs-Asian |
2.08969508364021E-11 |
| Caucasian-vs-AfricanAmerican |
2.367400E-01 |
| Caucasian-vs-Asian |
1.371030E-01 |
| AfricanAmerican-vs-Asian |
2.827900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.42489997578821E-09 |
| Normal-vs-Female |
6.99019730987516E-11 |
| Male-vs-Female |
1.552760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.33380031650677E-11 |
| Normal-vs-Age(41-60Yrs) |
2.97872837506929E-13 |
| Normal-vs-Age(61-80Yrs) |
5.71259994863738E-09 |
| Normal-vs-Age(81-100Yrs) |
4.580600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.848400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.287200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.840800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.668800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.918200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.568600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.920900E-03 |
| Classical-VS-Follicular |
7.787200E-01 |
| Classical-VS-Other |
8.736200E-01 |
| Classical-VS-Normal |
1.4143000104383E-09 |
| Tall-VS-Follicular |
2.380500E-02 |
| Tall-VS-Other |
4.914800E-01 |
| Tall-VS-Normal |
1.22599708163307E-11 |
| Follicular-VS-Other |
8.902200E-01 |
| Follicular-VS-Normal |
1.02330000029127E-08 |
| Other-VS-Normal |
2.488000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.1596947280832E-13 |
| Normal-vs-N1 |
3.86646270555957E-12 |
| N0-vs-N1 |
1.155820E-02 |
|
|
